Status:
UNKNOWN
Investigating the Role of Luminal Pressure on Arteriovenous Fistula Maturation
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Arteriovenous Fistula
Eligibility:
All Genders
20-100 years
Brief Summary
Introduction Arteriovenous fistula (AVF) is the preferred hemodialysis vascular access due to its higher patency and lower infection rate. However, its major weakness is suboptimal maturation rate. Al...
Detailed Description
Background: AVF is the preferred vascular access for maintenance hemodialysis. However, AVF is not an ideal vascular access without any drawback. Previous studies had revealed several risk factors of ...
Eligibility Criteria
Inclusion
- Patients with hemodialysis who receiving AVF.
- AVF created at both radial and brachial arteries
Exclusion
- Patients at age \<20 years old
- Patients who are unconscious or unable to sign the inform consent
- Patient in whom native AVF creation is shifted to arteriovenous graft placement
Key Trial Info
Start Date :
September 19 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 7 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04017806
Start Date
September 19 2018
End Date
May 7 2020
Last Update
July 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
Taipei, Taiwan, 116